<i>Pw1</i> deletion does not result in significant decrease in oxytocin production and release. by Anne-Lyse Denizot (3170142)

CyaA decreases the capacity of TLR-stimulated DCs to present soluble antigen to CD4⁺ T cells. by Irena Adkins (173166)

CaMKII inhibition does not alter dendritic spine density, but decreases dendritic length and complexity. by Jason R. Klug (132807)

Knockdown of GLUT1 decreases de uptake and phototoxicity of PcGal₁₆. by Patrícia M. R. Pereira (555179)

Knockdown of galectin-1 decreases de uptake and phototoxicity of PcGal₁₆. by Patrícia M. R. Pereira (555179)

Reduction of SIRT1 during DNA damage decreases the number of silent clones that have methylation. by Heather M. O'Hagan (271283)

“…One representative bisulfite sequenced clone is presented for each HSVTK silent clone. (B) A dot plot of the mean number of CpGs methylated per HSVTK silenced clone from either un-siRNA treated cells (untreated) (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000155#pgen-1000155-g005" target="_blank">Figure 5D & E</a>), non-target siRNA treated cells (NT), or SIRT1 siRNA treated cells (SIRT1). …”

Fibrinogen prevents plasma TTR thermal-induced protein aggregation and glycation decreases it chaperone activity. by Gonçalo da Costa (198731)

HAART does not affect CTLA-4 expression, but significantly decreases CD39 expression in Tregs. by Pietro Presicce (144163)

HAART decreased enhanced expression of cell cycling markers in Tregs from HIV-infected subjects. by Pietro Presicce (144163)

Analgesic effect of morphine (4 mg/kg) was decreased after consecutive daily injections in NAMT. by Ghazaleh Ghamkharinejad (11414825)

Depletion of circulating PMNs decreases the expansion of pericyte gaps and collagen IV LERs during inflammation. by Shijun Wang (89455)

SIRT1 expression in liver tumors and the inhibition of SIRT1 decreases hepatic tumorigenesis in mice. by Kyu Yun Jang (134932)

The ratio between the bias in the naïve SI and shuffle SI decreases with tuning specificity, but not with sample size. by Liron Sheintuch (12078310)

“…Data pooled from N = 9 simulations, each corresponding to behavioral data from a different mouse. (B) The bias ratio (mean ± SEM) decreases as a function of the true SI for a sample size of 1 minute (blue), 5 minutes (cyan) and 20 minutes (green). …”

Reduction of cholesterol levels by MβCD decreased APP localization in lipid rafts from CHO PS1 ΔE9 cells. by Yoon Young Cho (838272)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…<p>(<b>A–B</b>) Bath perfusion of DHPG for 3 min reduced GlyR-IPSCs (<b>A</b>; 70.2 ± 4.2% of baseline at 15–20 min post-DHPG, <i>t</i>[16] = 6.707, <i>p</i> < 0.001, paired Student <i>t</i> test), but not GABA_A-receptor–mediated IPSCs (<b>B</b>; 102.9 ± 3.3% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 0.347, <i>p</i> = 0.743) in spinal slices of mice. …”

Excel spreadsheet containing the underlying numerical data for Figs 1A, 1C, 1E, 1F, 1H, 2B, 2C, 2D, 2E, 2F, 3A, 3B, 3C, 3D, 3F, 4B, 4C, 4F, 4G, 5E, 6C, 6D, 6E, 6F, 6G, 7B, 7D, 8A,... by Jong-Seol Kang (14925926)

Vasodilator effect of BPP-BrachyNH₂ and captopril (10⁻⁹–3 × 10⁻⁵ M) on rat thoracic aorta. by Daniel Dias Rufino Arcanjo (536744)

Decrease in BAL IL-10 after thoracic trauma. by Jürg Hamacher (80081)

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for Brazil. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Caribbean. by Santiago Avila-Rios (3160959)

Subjects: